AAAAAA
Results:
1-21
|
Results: 21
Authors:
Gartner, CA
Thompson, SJ
Rettie, AE
Nelson, SD
Citation: Ca. Gartner et al., Human aromatase in high yield and purity by perfusion chromatography and its characterization by difference spectroscopy and mass spectrometry, PROT EX PUR, 22(3), 2001, pp. 443-454
Authors:
Cheesman, MJ
Kneller, MB
Kelly, EJ
Thompson, SJ
Yeung, CK
Eaton, DL
Rettie, AE
Citation: Mj. Cheesman et al., Purification and characterization of hexahistidine-tagged cyclohexanone monooxygenase expressed in Saccharomyces cerevisiae and Escherichia coli, PROT EX PUR, 21(1), 2001, pp. 81-86
Authors:
Rooseboom, M
Commandeur, JNM
Floor, GC
Rettie, AE
Vermeulen, NPE
Citation: M. Rooseboom et al., Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates, CHEM RES T, 14(1), 2001, pp. 127-134
Authors:
Kim, JS
Nafziger, AN
Gaedigk, A
Dickmann, LJ
Rettie, AE
Bertino, JS
Citation: Js. Kim et al., Effects of oral vitamin K on S- and R-Warfarin pharmacokinetics and pharmacodynamics: Enhanced safety of warfarin as a CYP2C9 probe, J CLIN PHAR, 41(7), 2001, pp. 715-722
Authors:
He, MX
Rettie, AE
Neal, J
Trager, WF
Citation: Mx. He et al., Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s, DRUG META D, 29(5), 2001, pp. 701-711
Authors:
Kilicarslan, T
Haining, RL
Rettie, AE
Busto, U
Tyndale, RF
Sellers, EM
Citation: T. Kilicarslan et al., Flunitrazepam metabolism by cytochrome P450S2C19 and 3A4, DRUG META D, 29(4), 2001, pp. 460-465
Authors:
Dickmann, LJ
Rettie, AE
Kneller, MB
Kim, RB
Wood, AJJ
Stein, CM
Wilkinson, GR
Schwarz, UI
Citation: Lj. Dickmann et al., Identification and functional characterization of a new CYP2C9 variant (CYP2C95) expressed among African Americans, MOLEC PHARM, 60(2), 2001, pp. 382-387
Authors:
Christmas, P
Jones, JP
Patten, CJ
Rock, DA
Zheng, YM
Cheng, SM
Weber, BM
Carlesso, N
Scadden, DT
Rettie, AE
Soberman, RJ
Citation: P. Christmas et al., Alternative splicing determines the function of CYP4F3 by switching substrate specificity, J BIOL CHEM, 276(41), 2001, pp. 38166-38172
Authors:
Henne, KR
Kunze, KL
Zheng, YM
Christmas, P
Soberman, RJ
Rettie, AE
Citation: Kr. Henne et al., Covalent linkage of prosthetic heme to CYP4 family P450 enzymes, BIOCHEM, 40(43), 2001, pp. 12925-12931
Authors:
Henne, KR
Fisher, MB
Iyer, KR
Lang, DH
Trager, WF
Rettie, AE
Citation: Kr. Henne et al., Active site characteristics of CYP4B1 probed with aromatic ligands, BIOCHEM, 40(29), 2001, pp. 8597-8605
Authors:
Kneller, MB
Cheesman, MJ
Rettie, AE
Citation: Mb. Kneller et al., ESI- and MALDI-MS analysis of cyclohexanone monooxygenase from Acinetobacter NCIB 9871, BIOC BIOP R, 282(4), 2001, pp. 899-903
Authors:
Rettie, AE
Lang, DH
Citation: Ae. Rettie et Dh. Lang, Can caffeine metabolism be used as an in-vivo probe for human flavin-containing monooxygenase activity?, PHARMACOGEN, 10(3), 2000, pp. 275-277
Authors:
Lang, DH
Rettie, AE
Citation: Dh. Lang et Ae. Rettie, In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms, BR J CL PH, 50(4), 2000, pp. 311-314
Authors:
Yeung, CK
Lang, DH
Thummel, KE
Rettie, AE
Citation: Ck. Yeung et al., Immunoquantitation of FMO1 in human liver, kidney, and intestine, DRUG META D, 28(9), 2000, pp. 1107-1111
Authors:
Dong, HJ
Haining, RL
Thummel, KE
Rettie, AE
Nelson, SD
Citation: Hj. Dong et al., Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen, DRUG META D, 28(12), 2000, pp. 1397-1400
Authors:
Hamman, MA
Haehner-Daniels, BD
Wrighton, SA
Rettie, AE
Hall, SD
Citation: Ma. Hamman et al., Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases - Comparison of human liver and kidney microsomes and mammalianenzymes, BIOCH PHARM, 60(1), 2000, pp. 7-17
Authors:
Rettie, AE
Haining, RL
Bajpai, M
Levy, RH
Citation: Ae. Rettie et al., A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin, EPILEPSY R, 35(3), 1999, pp. 253-255
Authors:
Koenigs, LL
Peter, RM
Hunter, AP
Haining, RL
Rettie, AE
Friedberg, T
Pritchard, MP
Shou, M
Rushmore, TH
Trager, WF
Citation: Ll. Koenigs et al., Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9, BIOCHEM, 38(8), 1999, pp. 2312-2319
Authors:
Haining, RL
Jones, JP
Henne, KR
Fisher, MB
Koop, DR
Trager, WF
Rettie, AE
Citation: Rl. Haining et al., Enzymatic determinants of the substrate specificity of CYP2C9: Role of B '-C loop residues in providing the pi-stacking anchor site for warfarin binding, BIOCHEM, 38(11), 1999, pp. 3285-3292
Authors:
He, MX
Korzekwa, KR
Jones, JP
Rettie, AE
Trager, WF
Citation: Mx. He et al., Structural forms of phenprocoumon and warfarin that are metabolized at theactive site of CYP2C9, ARCH BIOCH, 372(1), 1999, pp. 16-28
Authors:
Rettie, AE
Fisher, MB
Citation: Ae. Rettie et Mb. Fisher, Transformation enzymes: Oxidative; Non-P450, HANDBOOK OF DRUG METABOLISM, 1999, pp. 131-151
Risultati:
1-21
|